BlackRock Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$685M Sell
4,767,457
-133,007
-3% -$17.8M 0.69% 27
2016
Q3
$614M Buy
4,900,464
+824,588
+20% +$106M 0.63% 31
2016
Q2
$535M Buy
4,075,876
+86,959
+2% +$11.9M 0.54% 39
2016
Q1
$554M Buy
3,988,917
+226,691
+6% +$30.3M 0.58% 37
2015
Q4
$525M Buy
3,762,226
+1,099,697
+41% +$151M 0.56% 38
2015
Q3
$373M Buy
2,662,529
+146,810
+6% +$22.1M 0.4% 67
2015
Q2
$413M Buy
2,515,719
+69,150
+3% +$11M 0.43% 58
2015
Q1
$378M Buy
2,446,569
+2,040,123
+502% +$290M 0.39% 69
2014
Q4
$51.1M Buy
406,446
+36,686
+10% +$4.53M 0.05% 330
2014
Q3
$44.2M Sell
369,760
-55,659
-13% -$6.38M 0.04% 372
2014
Q2
$45.8M Sell
425,419
-6,379
-1% -$657K 0.04% 378
2014
Q1
$43M Buy
431,798
+259,039
+150% +$23.4M 0.04% 376
2013
Q4
$16M Sell
172,759
-576,743
-77% -$51.2M 0.02% 629
2013
Q3
$62.7M Buy
749,502
+13,149
+2% +$1.13M 0.06% 296
2013
Q2
$60.3M Buy
+736,353
New +$55.1M 0.06% 292

Other funds holding ELV

BlackRock Advisors's ELV Position: Q4 2016 in Review

BlackRock Advisors reduced its Elevance Health (ELV) stake by 2.7% in Q4 2016, selling an estimated $17.8M and leaving 4,767,457 shares worth $685M. The position accounts for 0.69% of the portfolio, ranked #27.

BlackRock Advisors first reported a position in ELV in Q2 2013 and has held it in 15 quarters since. 783 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • BlackRock Advisors held 4,767,457 shares of Elevance Health worth $685M as of Q4 2016.
  • BlackRock Advisors sold 133,007 Elevance Health shares in Q4 2016, an estimated $17.8M.
  • Elevance Health made up 0.69% of BlackRock Advisors's portfolio in Q4 2016, its #27 holding.
  • BlackRock Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 15 quarters since.
  • 783 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.